Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury

European Journal of Immunology

Volumn 45, Issue 2, 2015, Pages 531-543

  Volarevic, Vladislav ^a   Markovic, Bojana Simovic ^a   Bojic, Sanja ^a   Stojanovic, Maja ^a   Nilsson, Ulf ^b   Leffler, Hakon ^c   Besra, Gurdyal S ^d   Arsenijevic, Nebojsa ^a   Paunovic, Verica ^e   Trajkovic, Vladimir ^e   Lukic, Miodrag L ^a  

^a University of Kragujevac Medical Faculty   (Serbia)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Dendritic cells; Gal 3; Hepatitis; NKT cells; Regulatory T (Treg) cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA GALACTOSYLCERAMIDE; ASPARTATE AMINOTRANSFERASE; CD11B ANTIGEN; CD1D ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GALECTIN 3; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ALPHA-GALACTOSYLCERAMIDE; CD1D ANTIGEN, MOUSE; GALACTOSYLCERAMIDE; IL10 PROTEIN, MOUSE; LGALS3 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ADHESION; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; EMBRYO; EXPERIMENTAL HEPATITIS; GENE DELETION; IN VITRO STUDY; INFECTION SENSITIVITY; LIVER INJURY; MONONUCLEAR CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL MOTION; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; LIVER; METABOLISM; NATURAL KILLER CELL; PATHOLOGY; SIGNAL TRANSDUCTION; TOXIC HEPATITIS;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIGENS, CD1D; CELL MOVEMENT; DENDRITIC CELLS; DRUG-INDUCED LIVER INJURY; GALACTOSYLCERAMIDES; GALECTIN 3; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; KILLER CELLS, NATURAL; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923040035     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444849     Document Type: Article

References (24)

1. Fermino, M. L., Dias, F. C., Lopes, C. D., Souza, M. A., Cruz, A. K., Liu, F. T., Chammas, R. et al., Galectin-3 negatively regulates the frequency and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells and influences the course of Leishmania major infection. Eur. J. Immunol. 2013. 43:1806-1817.
2. Hsieh, W. C., Mackinnon, A. C., Lu, W. Y., Jung, J., Boulter, L., Henderson, N. C., Simpson, K. J. et al., Galectin-3 regulates hepatic progenitor cell expansion during liver injury. Gut 2014. In press. DOI: 10.1136/gutjnl-2013-306290.
3. Iacobini, C., Menini, S., Ricci, C., Blasetti Fantauzzi, C., Scipioni, A., Salvi, L., Serino, M. et al., Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. J. Hepatol. 2011. 54: 975-983.
4. Volarevic, V., Milovanovic, M., Ljujic, B., Pejnovic, N., Arsenijevic, N., Nilsson, U., Leffler, H. et al., Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 2012. 55: 1954-1964.
5. Radosavljevic, G., Volarevic, V., Jovanovic, I., Milovanovic, M., Pejnovic, N., Arsenijevic, N., Hsu, D. K. et al., The roles of galectin-3 in autoimmunity and tumor progression. Immunol. Res. 2012. 52: 100-110.
6. Johnston, B., Kim, C. H., Soler, D., Emoto, M. and Butcher, E. C., Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J. Immunol. 2003. 171: 2960-2969.
7. Subramanian, M., Kini, R., Madasu, M., Ohta, A., Nowak, M., Exley, M., Sitkovsky, M. et al., Extracellular adenosine controls NKT-cell-dependent hepatitis induction. Eur. J. Immunol. 2014. 44: 1119-1129.
8. Nagy, L., Would eating carrots protect your liver? A new role involving NKT cells for retinoic acid in hepatitis. Eur. J. Immunol. 2012. 42: 1677-1680.
9. Osman, Y., Kawamura, T., Naito, T., Takeda, K., van Kaer, L., Okumura, K. and Abo, T., Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur. J. Immunol. 2000. 30: 1919-1928.
10. Tiegs, G., Hentschel, J. and Wendel, A., A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992. 90: 196-203.
11. Biburger, M. and Tiegs, G., Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J. Immunol. 2005. 175: 1540-1550.
12. Hsu, D. K., Chernyavsky, A. I., Chen, H. Y., Yu, L, Grando, S. A. and Liu, F. T., Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J. Invest. Dermatol. 2009. 129: 573-583.
13. + regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice. J. Immunol. 2008. 181:7221-7229.
14. Rico, M. J., Rozados, V. R., Mainetti, L. E., Zacarias Fluck, M. F., Matar, P. and Scharovsky, O. G., Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model. Exp. Oncol. 2012. 34: 38-42.
15. Ronger-Savle, S., Valladeau, J., Claudy, A., Schmitt, D., Peguet-Navarro, J., Dezutter-Dambuyant, C., Thomas, L. et al., TGFbeta inhibits CD1d expression on dendritic cells. J. Invest. Dermatol. 2005. 124: 116-118.
16. Trobonjaca, Z., Leithäuser, F., Möller, P., Schirmbeck, R. and Reimann, J., Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J. Immunol. 2001. 167: 1413-1422.
17. Jeon, S. B., Yoon, H. J., Chang, C. Y., Koh, H. S., Jeon, S. H. and Park, E. J., Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway. J. Immunol. 2010. 185: 7037-7046.
18. Sasakawa, A., Tatsumi, T., Takehara, T., Yamaguchi, S., Yamamoto, M., Ohkawa, K., Miyagi, T. et al., Activated liver dendritic cells generate strong acquired immunity in alpha-galactosylceramide treatment. J. Hepatol. 2009. 50: 1155-1162.
19. Yoneyama, H., Matsuno, K., Zhang, Y., Murai, M., Itakura, M., Ishikawa, S., Hasegawa, G. et al., Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associatedlymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 2001. 193: 35-49.
20. Nakano, M., Saeki, C., Takahashi, H., Homma, S., Tajiri, H. and Zeniya, M., Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation. Clin. Exp. Immunol. 2012. 170: 274-282.
21. Battaglia, A., Buzzonetti, A., Baranello, C., Fanelli, M., Fossati, M., Catzola, V., Scambia, G. et al., Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β- induced regulatory T-cell development. Immunology 2013. 139:109-120.
22. Hsu, D. K., Yang, R. Y., Pan, Z., Yu, L., Salomon, D. R., Fung-Leung, W. P. and Liu, F. T., Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 2000. 156: 1073-1083.
23. Volarevic, V., Mitrovic, M., Milovanovic, M., Zelen, I., Nikolic, I., Mitrovic, S., Pejnovic, N. et al., Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J. Hepatol. 2012. 56:26-33.
24. Harada, M., Seino, K., Wakao, H., Sakata, S., Ishizuka, Y., Ito, T., Kojo, S, et al., Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Int. Immunol. 2004. 16: 241-247.